John Chester

John Chester

UNVERIFIED PROFILE

Are you John Chester?   Register this Author

Register author
John Chester

John Chester

Publications by authors named "John Chester"

Are you John Chester?   Register this Author

43Publications

1016Reads

21Profile Views

Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications.

Cancer Gene Ther 2020 Jan 6. Epub 2020 Jan 6.

Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41417-019-0156-0DOI Listing
January 2020

Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus.

Oncotarget 2018 May 29;9(41):26328-26341. Epub 2018 May 29.

Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25242DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995174PMC
May 2018

Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1.

Oncotarget 2017 Oct 28;8(49):85024-85039. Epub 2017 Jun 28.

Cardiff China Medical Research Collaborative, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689591PMC
October 2017

The Wales Cancer Research Centre: improving cancer care together.

Ecancermedicalscience 2017 19;11:ed65. Epub 2017 Apr 19.

Wales Cancer Research Centre, Cardiff University, University Hospital of Wales, Cardiff, CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2017.ed65DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406219PMC
April 2017

Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.

J Clin Oncol 2017 Jan 28;35(1):48-55. Epub 2016 Oct 28.

Thomas Powles, Shah-Jalal Sarker, Charlotte Ackerman, and Daniel Berney, Queen Mary University of London; Simon Hughes and Simon Chowdhury, Guy's and St Thomas' National Health Service (NHS) Foundation Trust, London; Robert A. Huddart, Institute of Cancer Research, Sutton; Tony Elliott, Christie Hospital NHS Foundation Trust, Manchester; Robert Jones, University of Glasgow, Glasgow; Syed Hussain, University of Liverpool, Liverpool; Simon Crabb, University of Southampton, Southampton; Satinder Jagdev, St James's University Hospital, Leeds; John Chester, Cardiff University, Cardiff; Serena Hilman, Bristol Haematology and Oncology Centre, Bristol; Mark Beresford, Royal United Hospitals Bath, Bath; Graham Macdonald, Aberdeen Royal Infirmary, Aberdeen; Sundar Santhanam, Nottingham University Hospitals NHS Trust, Nottingham; John A. Frew, Northern Centre for Cancer Care, Newcastle upon Tyne; and Andrew Stockdale, University Hospital, Coventry, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3468DOI Listing
January 2017

Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.

Oncotarget 2016 May;7(19):27926-37

Department of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053699PMC
http://dx.doi.org/10.18632/oncotarget.8545DOI Listing
May 2016

Personalised cancer medicine.

Int J Cancer 2015 Jul 12;137(2):262-6. Epub 2014 May 12.

Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28940DOI Listing
July 2015

Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?

Clin Cancer Res 2011 Jul 16;17(13):4214-24. Epub 2011 May 16.

Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2848DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131422PMC
July 2011

Fulminant hepatic failure in a patient with advanced extragonadal germ cell tumour.

BMJ Case Rep 2010 Sep 29;2010. Epub 2010 Sep 29.

Department of Medical Oncology, St James's Institute of Oncology, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr.01.2010.2661DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027936PMC
September 2010

Lumbar chemical sympathectomy in peripheral vascular disease: does it still have a role?

Int J Surg 2009 Apr 27;7(2):145-9. Epub 2009 Jan 27.

Department of Vascular Surgery and Anaesthesia, Taunton and Somerset NHS Trust, Musgrove Park, Taunton TA1 5DA, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijsu.2009.01.004DOI Listing
April 2009

Treg Depletion-enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus.

Mol Ther 2008 Jul 8;16(7):1217-1226. Epub 2016 Dec 8.

Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Cancer Research UK Clinical Centre, Leeds Teaching Hospitals NHS Trust, University of Leeds, St. James's University Hospital, Leeds, UK; Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK; Department of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2008.83DOI Listing
July 2008

Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy.

Cancer Res 2007 Jan;67(1):300-8

Molecular Medicine Program and Department of Immunology, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-1017DOI Listing
January 2007

Surgical treatment of varicose veins: effect of rationing.

Ann R Coll Surg Engl 2006 Jan;88(1):37-9

Department of Vascular Surgery, Taunton and Somerset Hospital, Taunton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1308/003588406X82998DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1963610PMC
January 2006

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells.

Nat Med 2005 Oct 18;11(10):1073-81. Epub 2005 Sep 18.

Molecular Medicine Program, Department of Immunology, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm1297DOI Listing
October 2005

Systemic chemotherapy for patients with bladder cancer--current controversies and future directions.

Cancer Treat Rev 2004 Jun;30(4):343-58

Cancer Research UK Clinical Centre in Leeds, St. James' University Hospital, Beckett Street, Leeds LS9 7TF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2003.12.005DOI Listing
June 2004